Cargando…

Pattern of InhA and KatG mutations in isoniazid monoresistant Mycobacterium tuberculosis isolates

AIMS AND OBJECTIVES: The aim of the study is to detect the pattern of genetic mutation, i.e., InhA or KatG or both (InhA and katG) in isoniazid (INH) monoresistant mycobacteria and to correlate with the pattern in multidrug-resistant (MDR) isolates. MATERIALS AND METHODS: In this study, a quantitati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Charan, Ashok Singh, Gupta, Neeraj, Dixit, Ramakant, Arora, Piyush, Patni, Tarun, Antony, Kalliath, Singh, Manisha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353940/ https://www.ncbi.nlm.nih.gov/pubmed/32367844 http://dx.doi.org/10.4103/lungindia.lungindia_204_19

Ejemplares similares

Detection of KatG/inhA Mutation to Guide Isoniazid and Ethionamide Use for Drug-resistant Tuberculosis
por: Namburete, Evangelina
Publicado: (2017)

Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic
por: Isakova, Jainagul, et al.
Publicado: (2018)

Molecular Characterization of katG and inhA Mutations by Genotype MTBDRplus Line Probe Assay To Guide Isoniazid and Ethionamide Use for Drug-Resistant Tuberculosis
por: Ranjan, K. P., et al.
Publicado: (2023)

The impact of combined gene mutations in inhA and ahpC genes on high levels of isoniazid resistance amongst katG non-315 in multidrug-resistant tuberculosis isolates from China
por: Liu, Liguo, et al.
Publicado: (2018)

In house reverse membrane hybridisation assay versus GenoType MTBDRplus and their performance to detect mutations in the genes rpoB, katG and inhA
por: Ferreira, Sergio Luiz Montego, et al.
Publicado: (2014)

Frequency of rpoB, katG, and inhA Gene Polymorphisms Associated with Multidrug-Resistant Mycobacterium tuberculosis Complex Isolates among Ethiopian TB Patients: A Systematic Review
por: Seid, Aynias, et al.
Publicado: (2022)

Two Novel katG Mutations Conferring Isoniazid Resistance in Mycobacterium tuberculosis
por: Hsu, Li-Yu, et al.
Publicado: (2020)

Clarity with INHindsight: High-Dose Isoniazid for Drug-Resistant Tuberculosis with inhA Mutations
por: Wasserman, Sean, et al.
Publicado: (2020)

Isoniazid resistance and the point mutation of codon 463 of katG gene of Mycobacterium tuberculosis.
por: Shim, T. S., et al.
Publicado: (1997)

Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates
por: Torres, Jessica N, et al.
Publicado: (2015)

Molecular Dynamics Assisted Mechanistic Study of Isoniazid-Resistance against Mycobacterium tuberculosis InhA
por: Kumar, Vivek, et al.
Publicado: (2015)

Inducing vulnerability to InhA inhibition restores isoniazid susceptibility in drug resistant Mycobacterium tuberculosis
por: Harrison, Gregory A., et al.
Publicado: (2023)

Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America
por: Dalla Costa, Elis R, et al.
Publicado: (2009)

Isoniazid MIC and KatG Gene Mutations among Mycobacterium tuberculosis Isolates in Northwest of Iran
por: Moaddab, Seed Reza, et al.
Publicado: (2011)

Minor Contribution of inhA-15 Mutations to the Rapid Detection of Isoniazid Resistance in Mycobacterium Tuberculosis Isolates
por: Abkar, Roya, et al.
Publicado: (2016)

Molecular Analysis of katG Encoding Catalase-Peroxidase from Clinical Isolate of Isoniazid-Resistant Mycobacterium tuberculosis
por: Purkan, P, et al.
Publicado: (2018)

Impact of Isoniazid Resistance-Conferring Mutations on the Clinical Presentation of Isoniazid Monoresistant Tuberculosis
por: Dantes, Raymund, et al.
Publicado: (2012)

Binding Thermodynamics and Dissociation Kinetics Analysis Uncover the Key Structural Motifs of Phenoxyphenol Derivatives as the Direct InhA Inhibitors and the Hotspot Residues of InhA
por: Zhang, Qianqian, et al.
Publicado: (2022)

Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014
por: Cornejo Garcia, Jose Gabriel, et al.
Publicado: (2018)

Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors
por: Sabbah, Mohamad, et al.
Publicado: (2020)

Mycobacterium tuberculosis Is Resistant to Isoniazid at a Slow Growth Rate by Single Nucleotide Polymorphisms in katG Codon Ser(315)
por: Jeeves, Rose E., et al.
Publicado: (2015)

Virulence of Mycobacterium tuberculosis after Acquisition of Isoniazid Resistance: Individual Nature of katG Mutants and the Possible Role of AhpC
por: Nieto R, Luisa Maria, et al.
Publicado: (2016)

Drug resistance and the genotypic characteristics of rpoB and katG in rifampicin- and/or isoniazid-resistant Mycobacterium tuberculosis isolates in central Vietnam
por: Nguyen, Thi Binh Nguyen, et al.
Publicado: (2023)

Intracellular targeting of ascomycetous catalase-peroxidases (KatG1s)
por: Zámocký, Marcel, et al.
Publicado: (2013)

Delphi Survey on the Current and Future Korean Guidelines for Isoniazid-Monoresistant Tuberculosis
por: Seo, Wan, et al.
Publicado: (2023)

Discovery of a cofactor-independent inhibitor of Mycobacterium tuberculosis InhA
por: Xia, Yi, et al.
Publicado: (2018)

Correction to Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors
por: Sabbah, Mohamad, et al.
Publicado: (2020)

Investigation of Ser315 Substitutions within katG Gene in Isoniazid-Resistant Clinical Isolates of Mycobacterium tuberculosis from South India
por: Unissa, A. Nusrath, et al.
Publicado: (2015)

Correlation of inhA mutations and ethionamide susceptibility: Experience from national reference center for tuberculosis
por: Sarin, Rohit, et al.
Publicado: (2021)

KatG-Mediated Oxidation Leading to Reduced Susceptibility of Bacteria to Kanamycin
por: Loewen, Peter C., et al.
Publicado: (2018)

Prevalence and outcome of isoniazid-monoresistant tuberculosis at a university hospital in Saudi Arabia
por: Binkhamis, Khalifa M., et al.
Publicado: (2021)

InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis
por: Flint, Lindsay, et al.
Publicado: (2020)

Predictive Power of ETRE Polymorphism and Katg463 Mutation to INH-Resistance of M.tuberculosis
por: WEN, Yu-feng, et al.
Publicado: (2015)

Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor
por: Martínez-Hoyos, María, et al.
Publicado: (2016)

Clinical Characteristics and Treatment Outcomes of Patients with Low- and High-Concentration Isoniazid-Monoresistant Tuberculosis
por: Wang, Tsai-Yu, et al.
Publicado: (2014)

A Retrospective Analysis of Isoniazid-Monoresistant Tuberculosis: Among Iranian Pulmonary Tuberculosis Patients
por: Varahram, Mohammad, et al.
Publicado: (2014)

In silico study of phytochemicals contained in Brucea javanica in inhibiting the InhA enzyme as antituberculosis
por: Sulistyowaty, Melanny Ika, et al.
Publicado: (2023)

Effect of the explicit flexibility of the InhA enzyme from Mycobacterium tuberculosis in molecular docking simulations
por: Cohen, Elisangela ML, et al.
Publicado: (2011)

Screening of a Novel Fragment Library with Functional Complexity against Mycobacterium tuberculosis InhA
por: Prati, Federica, et al.
Publicado: (2018)

The Value of the inhA Mutation Detection in Predicting Ethionamide Resistance Using Melting Curve Technology
por: Song, Yanhua, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_74n5rd5i8m42m1kcp586j78583